The Cooper Companies, Inc. (COO) Financials
COO Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2024-01-31 | 12.0 billion | 4.3 billion |
| 2023-10-31 | 11.7 billion | 4.1 billion |
| 2023-07-31 | 11.7 billion | 4.2 billion |
| 2023-04-30 | 11.5 billion | 4.2 billion |
COO Free Cash Flow and Stock based compensation
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2024-01-31 | 4.6 million | ? |
| 2023-10-31 | 29.2 million | -44.7 million |
| 2023-07-31 | 51.6 million | 15.5 million |
| 2023-04-30 | 50.6 million | 15.1 million |
COO Net Income
| Date | Net Income |
|---|---|
| 2024-01-31 | 81.2 million |
| 2023-10-31 | 84.5 million |
| 2023-07-31 | 85.3 million |
| 2023-04-30 | 39.8 million |
COO Cash and Debt
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2024-01-31 | 135.3 million | - | 4.3 million |
| 2023-10-31 | 120.8 million | - | 4.4 million |
| 2023-07-31 | 117.3 million | 2.5 billion | 19.9 million |
| 2023-04-30 | 111.9 million | 2.6 billion | 19.5 million |
COO Shares Outstanding
COO Expenses
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2024-01-31 | 118.1 million | 39.5 million | 380.9 million | - |
| 2023-10-31 | 145.0 million | 36.7 million | 387.6 million | - |
| 2023-07-31 | 90.9 million | 36.5 million | 375.2 million | - |
| 2023-04-30 | 73.6 million | 32.6 million | 407.5 million | - |
COO Cost of Revenue
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2024-01-31 | 931.6 million | 358.1 million |
| 2023-10-31 | 927.1 million | 320.6 million |
| 2023-07-31 | 930.2 million | 320.2 million |
| 2023-04-30 | 877.4 million | 294.5 million |
COO
Price: $88.84
Dividend Yield: 0.00%
Forward Dividend Yield: 0.01%
Payout Ratio: 0.13%
Dividend Per Share: 0.01 USD
Earnings Per Share: 1.45 USD
P/E Ratio: 63.83
Exchange: NMS
Sector: Healthcare
Industry: Medical Instruments & Supplies
Volume: 261400
Ebitda: 153.9 millionMarket Capitalization: 19.2 billion
Average Dividend Frequency: 2
Years Paying Dividends: 25